Khan MH,Abbas A .2014 .The importance of clinical pharmacists in health care system. Med Sci, 11 : 80-1.
.1993 .The Role of the Pharmacist in the Health Care System. Report of a WHO Meeting Tokyo, Japan; 31 August‑3 September, : .
Wolstenholme B .2011 .Medication‑related problems in geriatric pharmacology. Aging Well, 4 : 8.
Andreazza RS,Silveira De Castro M,Sippel Köche P,Heineck I. .2011 .Causes of drug‑related problems in the emergency room of a hospital in Southern Brazil. Gac Sanit, 25 : 501-6.
Naqvi AA,McGarry K .2014 .. , : 1-105.
Viktil KK,Blix HS,Moger TA,Reikvam A .2007 .Polypharmacy as commonly defined is an indicator of limited value in the assessment of drugr‑elated problems. Br J Clin Pharmacol, 63 : 187-95.
Vinks TH,Egberts TC,de Lange TM .2009 .Pharmacist‑based medication review reduces potential drug‑related problems in the elderly: The SMOG controlled trial. Drugs Aging, 26 : 123-33.
Fu AZ,Liu GG,Christensen DB .2004 .Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc, 52 : 1934-9.
Abbas A,Khan N. .2014 .Clinical trials involving pharmacists in Pakistan's healthcare system: A leap from paper to practice. Pharmacy, 2 : 244-7.
. .American Association for Clinical Chemistry AACC. 2016 Mar, 20 : .
DiPiro JT,Talbert RL,McGraw‑Hill Education RL .2014 .Pharmacotherapy: A Pathophysiologic Approach. , : .
Metformin . .. ID20. [Last accessed on 2016 Mar, 21 : .
Clinic Cleveland .2010 .Centre for Continuing Education. [Last accessed on 2016 Mar, 21 : .
Alsaad KO,Herzenberg AM .2007 .Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: An update. J Clin Pathol, 60 : 18-26.
Qian Y,Feldman E,Pennathur S,Kretzler M,Brosius FC .2008 .From fibrosis to sclerosis: Mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes, 57 : 1439-45.
. .‑herapy i‑na‑dultsi‑nh‑ospitala‑lgorithmposters‑. et1‑91627821. [Last accessed on 2016 Mar, 22 : .
. .choosingantihypertensive‑drug‑treatment‑2. 2016 Mar, 22 : .
.2015 .insulint‑herapy 2‑. [Last accessed on 2016 Mar, 22 : .
Spiromide . .. [Last accessed on 2016 Mar, 22 : .
Furosemide . .. 2016 Mar, 22 : 0.
. .Scottish Intercollegiate Guidelines Network SIGN. Managing Asthma in Adults; 2014. [Last accessed on 2016 Mar, 22 : .
Edema Pulmonary . .. [Last accessed on 2016 Mar, 22 : .
Kataoka H,Matsuno O .2008 .Age‑related pulmonar y crackles (rales) in asymptomatic cardiovascular patients. Ann Fam Med, 6 : 239-45.
.2013 .20 v s 3 . p d f / a t _ d o w n l o a d / f i l e . [ L a s t a c c e s s e d o n 2016 Mar 22]. /RTI%20abbreviated%20 Antibiotic%20guidance%20Aug%202013%20update%, 69 : .
.2012 .National Institute for Health and Care Excellence NICE. A n t i b i o t i c P re s c r i b i n g Fo r Re s p i r a t o r y Tr a c t Infections. Last accessed on 2016 Mar, 23 : .
Hlatky MA,Solomon MD,Shilane D,Leong TK,Brindis R,Go AS .2013 .Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol, 61 : 295-301.
.2012 .Scottish Intercollegiate Guidelines Network SIGN. Heart Disease. [Last accessed on 2016 Mar, 23 : .
Okrainec K,Platt R,Pilote L,Eisenberg MJ L .2005 .Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials. J Am Coll Cardiol, 45 : 177-84.
Abbas A .2014 .Hypertriglyceridemia: What is it and how it is managed - A review. Int J Pharmacother, 4 : 32-5.
Abbas A .2013 .The association of dyslipidemia with osteoporosis: A case report. El Med J, 1 : 3.
Ravi SP .2009 .Medicines use in primary care in developing and transitional countries: Fact book summarizing results from studies reported between 1990 and 2006. , 87 : 804.
. .‑ prevention/lipidmodification‑therapy ‑for‑preventing‑cardiovasculardisease#content=view‑node%3Anodes‑secondary ‑ prevention. [Last accessed on 2016 Mar, 24 : .
Radcliffe KA,Campbell WW .2008 .Statin myopathy. Curr Neurol Neurosci Rep, 8 : 66-72.
Torres PA,Helmstetter JA,Kaye AM,Kaye AD .2015 .Rhabdomyolysis: Pathogenesis, diagnosis, and treatment. Ochsner J, 15 : 58-69.
Athyros VG,Papageorgiou A A,Demitriadis DS,Kontopoulos AG . .Atorvastatin plus pravastatin for the. , : .